California 2019-2020 Regular Session

California Assembly Bill AB824

Introduced
2/20/19  
Refer
3/4/19  
Refer
3/4/19  
Report Pass
3/27/19  
Report Pass
3/27/19  
Refer
3/27/19  
Refer
3/27/19  
Report Pass
4/9/19  
Refer
4/11/19  
Refer
4/11/19  
Refer
4/24/19  
Report Pass
5/16/19  
Report Pass
5/16/19  
Engrossed
5/24/19  
Refer
5/24/19  
Refer
6/6/19  
Refer
6/6/19  
Report Pass
6/17/19  
Report Pass
6/17/19  
Refer
6/17/19  
Report Pass
7/5/19  
Report Pass
7/5/19  
Refer
7/5/19  
Refer
7/5/19  
Report Pass
7/10/19  
Refer
7/11/19  
Refer
8/12/19  
Refer
8/12/19  
Report Pass
9/3/19  
Report Pass
9/3/19  
Enrolled
9/12/19  
Enrolled
9/12/19  
Chaptered
10/7/19  
Chaptered
10/7/19  
Passed
10/7/19  

Caption

Business: preserving access to affordable drugs.

Companion Bills

No companion bills found.

Similar Bills

CT HB06619

An Act Concerning Prohibiting Pay For Delay.

RI H5913

Provides that an agreement resolving a patent infringement claim, in connection with the sale of a pharmaceutical product, is to be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value.

CT SB00269

An Act Concerning The Availability Of Generic Pharmaceuticals.

CT SB00251

An Act Concerning The Availability Of Generic Pharmaceuticals.

US SB1096

Preserve Access to Affordable Generics and Biosimilars Act

CA SB838

Health care: prescription drugs.

CA SB852

Health care: prescription drugs.

US SB1040

Drug Competition Enhancement Act